Uromems

Uromems company information, Employees & Contact Information

Explore related pages

Related company profiles:

UroMems is a biotechnology company based out of 5, rue Raymond Chanas, 38320, Eybens, FRANCE

Company Details

Employees
69
Founded
-
Address
5 Rue Raymond Chanas, Eybens,38320,france
Email
in****@****ems.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
EYBENS
Looking for a particular Uromems employee's phone or email?

Uromems Questions

News

UroMems Receives Clearance from the FDA and the French ANSM for Initiating Landmark Pivotal Clinical Study of UroActive® Smart Implant to Treat Male Stress Urinary Incontinence - Yahoo Finance

UroMems Receives Clearance from the FDA and the French ANSM for Initiating Landmark Pivotal Clinical Study of UroActive® Smart Implant to Treat Male Stress Urinary Incontinence Yahoo Finance

UroMems Receives Clearance from the FDA and the French ANSM for Initiating Landmark Pivotal Clinical Study of UroActive® Smart Implant to Treat Male Stress Urinary Incontinence - PR Newswire

UroMems Receives Clearance from the FDA and the French ANSM for Initiating Landmark Pivotal Clinical Study of UroActive® Smart Implant to Treat Male Stress Urinary Incontinence PR Newswire

UroMems Announces Successful Results in First-Ever Female Clinical Feasibility Study of UroActive® Smart Implant for Stress Urinary Incontinence Treatment - PR Newswire

UroMems Announces Successful Results in First-Ever Female Clinical Feasibility Study of UroActive® Smart Implant for Stress Urinary Incontinence Treatment PR Newswire

UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors - Yahoo Finance

UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors Yahoo Finance

Clinical trials of UroActive System receive support from Series C Financing - Urology Times

Clinical trials of UroActive System receive support from Series C Financing Urology Times

UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence - PR Newswire

UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence PR Newswire

UroMems Initiates First-in-Human Study of Its Smart Implant to Treat Stress Urinary Incontinence - PR Newswire

UroMems Initiates First-in-Human Study of Its Smart Implant to Treat Stress Urinary Incontinence PR Newswire

UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient - PR Newswire

UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient PR Newswire

Top Uromems Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant